Illumina stock trades at EUR 239.58 as Leerink lifts target

Illumina stock (ISIN US4523271090) was trading at EUR 239.58 at Lang & Schwarz on September 30, 2026 at 12:39 p.m. CEST, down 0.53 percent versus the prior close of EUR 240.85. The latest analyst revision puts the company back under a demanding valuation test after a strong earnings run.

Leerink raises its target

According to Yahoo Finance on September 29, 2026, Leerink Partners maintained its Outperform rating and raised its price target from USD 220.00 to USD 300.00. The new target is USD 27.00 above the USD 273.00 level cited in the same market context, placing the analyst view above the recent US quotation.

The revision matters because the market has already repriced Illumina sharply. Yahoo Finance lists a 52-week range of USD 88.00 to USD 278.99 and a market capitalization of USD 41.1 billion as of September 29, 2026, leaving the share price near the upper end of its annual range.

Q2 earnings set the benchmark

Illumina's Q2 FY26 results provide the fundamental reference point. Yahoo Finance reports revenue of USD 1.16 billion and earnings of USD 207.0 million for the quarter ended June 28, 2026, with a profit margin of 17.86 percent.

EPS was USD 1.31 in Q2 FY26 versus a USD 1.23 estimate, a USD 0.08 beat. That comparison gives the valuation a concrete earnings anchor, while the target revision shows how quickly expectations have moved alongside the stock.

Index membership adds a second driver

Index positioning also changed in September. MarketScreener reported that Illumina was added to the S&P 500 on September 20, 2026, alongside additions to several S&P index variants. That change can broaden passive-fund demand, but the USD 300.00 target also raises the hurdle for another valuation expansion.

Illumina develops sequencing and array-based technologies for genetic and genomic analysis. The company's website describes products spanning sequencing platforms, consumables, software and data analysis for research and clinical applications, including oncology and reproductive health.

Illumina stock stays below its prior close

At Lang & Schwarz, Illumina stock was trading at EUR 239.58 on September 30, 2026 at 12:39 p.m. CEST, down 0.53 percent from the prior close of EUR 240.85 on September 29, 2026. The Nasdaq-listed shares remain tied to the USD 1.31 Q2 EPS result and the USD 300.00 Leerink target as the next valuation checkpoints emerge.

More news and analyses on Illumina stock